112 related articles for article (PubMed ID: 27228057)
1. BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.
Wu YY; Kumar R; Iida R; Bagavant H; Alarcón-Riquelme ME
PLoS One; 2016; 11(5):e0156302. PubMed ID: 27228057
[TBL] [Abstract][Full Text] [Related]
2. The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity.
Ramirez-Ortiz ZG; Prasad A; Griffith JW; Pendergraft WF; Cowley GS; Root DE; Tai M; Luster AD; El Khoury J; Hacohen N; Means TK
Nat Immunol; 2015 May; 16(5):495-504. PubMed ID: 25848864
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.
Bodega-Mayor I; Delgado-Wicke P; Arrabal A; Alegría-Carrasco E; Nicolao-Gómez A; Jaén-Castaño M; Espadas C; Dopazo A; Martín-Gayo E; Gaspar ML; de Andrés B; Fernández-Ruiz E
Cell Mol Life Sci; 2024 Apr; 81(1):199. PubMed ID: 38683377
[TBL] [Abstract][Full Text] [Related]
4. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice.
Rubtsov AV; Rubtsova K; Kappler JW; Marrack P
Immunol Res; 2013 Mar; 55(1-3):210-6. PubMed ID: 22945807
[TBL] [Abstract][Full Text] [Related]
5. TLR7 Activation Accelerates Cardiovascular Pathology in a Mouse Model of Lupus.
Elshikha AS; Teng XY; Kanda N; Li W; Choi SC; Abboud G; Terrell M; Fredenburg K; Morel L
Front Immunol; 2022; 13():914468. PubMed ID: 35860280
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus.
Sang A; Zheng YY; Yin Y; Dozmorov I; Li H; Hsu HC; Mountz JD; Morel L
PLoS One; 2014; 9(8):e102151. PubMed ID: 25093822
[TBL] [Abstract][Full Text] [Related]
7. TLR7 gain-of-function genetic variation causes human lupus.
Brown GJ; Cañete PF; Wang H; Medhavy A; Bones J; Roco JA; He Y; Qin Y; Cappello J; Ellyard JI; Bassett K; Shen Q; Burgio G; Zhang Y; Turnbull C; Meng X; Wu P; Cho E; Miosge LA; Andrews TD; Field MA; Tvorogov D; Lopez AF; Babon JJ; López CA; Gónzalez-Murillo Á; Garulo DC; Pascual V; Levy T; Mallack EJ; Calame DG; Lotze T; Lupski JR; Ding H; Ullah TR; Walters GD; Koina ME; Cook MC; Shen N; de Lucas Collantes C; Corry B; Gantier MP; Athanasopoulos V; Vinuesa CG
Nature; 2022 May; 605(7909):349-356. PubMed ID: 35477763
[TBL] [Abstract][Full Text] [Related]
8. TLR7/TLR8 activation and susceptibility genes synergize to breach gut barrier in a mouse model of lupus.
Ma L; Terrell M; Brown J; Castellanos Garcia A; Elshikha A; Morel L
Front Immunol; 2023; 14():1187145. PubMed ID: 37483626
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.
Jenks SA; Cashman KS; Zumaquero E; Marigorta UM; Patel AV; Wang X; Tomar D; Woodruff MC; Simon Z; Bugrovsky R; Blalock EL; Scharer CD; Tipton CM; Wei C; Lim SS; Petri M; Niewold TB; Anolik JH; Gibson G; Lee FE; Boss JM; Lund FE; Sanz I
Immunity; 2018 Oct; 49(4):725-739.e6. PubMed ID: 30314758
[TBL] [Abstract][Full Text] [Related]
10. Altered X-chromosome inactivation predisposes to autoimmunity.
Huret C; Ferrayé L; David A; Mohamed M; Valentin N; Charlotte F; Savignac M; Goodhardt M; Guéry JC; Rougeulle C; Morey C
Sci Adv; 2024 May; 10(18):eadn6537. PubMed ID: 38701219
[TBL] [Abstract][Full Text] [Related]
11. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.
Richez C; Yasuda K; Bonegio RG; Watkins AA; Aprahamian T; Busto P; Richards RJ; Liu CL; Cheung R; Utz PJ; Marshak-Rothstein A; Rifkin IR
J Immunol; 2010 Jan; 184(2):796-806. PubMed ID: 20007534
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 7 deficiency suppresses type 1 diabetes development by modulating B-cell differentiation and function.
Huang J; Peng J; Pearson JA; Efthimiou G; Hu Y; Tai N; Xing Y; Zhang L; Gu J; Jiang J; Zhao H; Zhou Z; Wong FS; Wen L
Cell Mol Immunol; 2021 Feb; 18(2):328-338. PubMed ID: 33432061
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus.
Al-Azab M; Idiiatullina E; Liu Z; Lin M; Hrovat-Schaale K; Xian H; Zhu J; Yang M; Lu B; Zhao Z; Liu Y; Chang J; Li X; Guo C; Liu Y; Wu Q; Chen J; Lan C; Zeng P; Cui J; Gao X; Zhou W; Zhang Y; Zhang Y; Masters SL
Nat Immunol; 2024 Jun; 25(6):969-980. PubMed ID: 38831104
[TBL] [Abstract][Full Text] [Related]
14. TLR7 activation of age-associated B cells mediates disease in a mouse model of primary Sjögren's disease.
Punnanitinont A; Kasperek EM; Zhu C; Yu G; Miecznikowski JC; Kramer JM
J Leukoc Biol; 2024 Feb; 115(3):497-510. PubMed ID: 37930711
[TBL] [Abstract][Full Text] [Related]
15. Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus
Graham JH; Yoachim SD; Gould KA
Front Immunol; 2020; 11():582214. PubMed ID: 33240270
[TBL] [Abstract][Full Text] [Related]
16. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.
Smith N; Rodero MP; Bekaddour N; Bondet V; Ruiz-Blanco YB; Harms M; Mayer B; Bader-Meunier B; Quartier P; Bodemer C; Baudouin V; Dieudonné Y; Kirchhoff F; Sanchez Garcia E; Charbit B; Leboulanger N; Jahrsdörfer B; Richard Y; Korganow AS; Münch J; Nisole S; Duffy D; Herbeuval JP
Sci Adv; 2019 Jul; 5(7):eaav9019. PubMed ID: 31309143
[TBL] [Abstract][Full Text] [Related]
17. Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice.
Snyder JM; Treuting PM; Nagy L; Yam C; Yi J; Brasfield A; Nguyen LP; Hajjar AM
PLoS One; 2014; 9(9):e107257. PubMed ID: 25229618
[TBL] [Abstract][Full Text] [Related]
18. Increased development of T-bet
Sullivan KA; Chapman C; Lu L; Ashbrook DG; Wang Y; Alduraibi FK; Lu C; Sun CW; Liu S; Williams RW; Mountz JD; Hsu HC
Clin Immunol; 2023 Dec; 257():109842. PubMed ID: 37981105
[TBL] [Abstract][Full Text] [Related]
19. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Bracken SJ; Suthers AN; DiCioccio RA; Su H; Anand S; Poe JC; Jia W; Visentin J; Basher F; Jordan CZ; McManigle WC; Li Z; Hakim FT; Pavletic SZ; Bhuiya NS; Ho VT; Horwitz ME; Chao NJ; Sarantopoulos S
Blood Adv; 2024 Feb; 8(3):667-680. PubMed ID: 38113462
[TBL] [Abstract][Full Text] [Related]
20. Molecular functions of the transcription factors E2A and E2-2 in controlling germinal center B cell and plasma cell development.
Wöhner M; Tagoh H; Bilic I; Jaritz M; Poliakova DK; Fischer M; Busslinger M
J Exp Med; 2016 Jun; 213(7):1201-21. PubMed ID: 27261530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
